KATELYN AMOS: Open Payments
NPI 1063994424 · KALAMAZOO, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$159 in 6 payments from 6 companies in 2025. Trend: 2023 $317 · 2024 $400 · 2025 $159
Food & beverage: $99Education: $60
| Company | Payments | Amount |
|---|---|---|
| SANOFI-AVENTIS U.S. LLC | 1 | $60 |
| Pulmonx Corporation | 1 | $29 |
| Verona Pharma, Inc. | 1 | $23 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $18 |
| GlaxoSmithKline, LLC. | 1 | $15 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: DUPIXENT, CHARTIS CATHETER, Ohtuvayre, JASCAYD, NUCALA, TEZSPIRE.
Industry payments across MI — which companies pay providers there.
